Physician profile
Donald E Cutlip
NPI 1396777827
$16,789.62
in general payments reported to CMS, 2019-2025
8 companies · $7,600 in 2025
The $7,600 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $82.51 · 2022: $2,046 · 2024: $6,912 · 2025: $7,600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,750 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,600 · Travel and Lodging: $651 · Food and Beverage: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,750.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,600.00 |
| Travel and Lodging | $650.81 |
| Food and Beverage | $510.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,702.96 | 2024 | |
| Cordis US Corp. | $6,162.08 | 2022-2025 | Selution Slr Pta, Selution Slr Ptca, Selution Slrpta |
| Abiomed | $2,000.00 | 2022 | |
| Magenta Medical INC | $1,500.00 | 2025 | |
| Celonova Biosciences, INC. | $231.99 | 2019-2020 | |
| Abbott Laboratories | $104.05 | 2025 | Portico |
| Edwards Lifesciences Corporation | $88.54 | 2024 | Sapien 3 Ultra Resilia |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Cutlip listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.